Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Focal Infection, Dental

ClinicalTrials.gov lists 2 trials for Focal Infection, Dental or a narrower condition beneath it. GlaxoSmithKline has the most among industry and government lead sponsors, with 1.

MeSH D005491 Infections C01 C07
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 2 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 2 Lead sponsors Lead sponsors 1 Publications Publications 18 Trials started per year Trials started per year 2 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 2 Lead sponsors Lead sponsors 1 Publications Publications 18

Rows recorded per section

4 sections measured, none recorded · 1 not measured yet · 1 not computed

2 of the 2 trials are tagged with Focal Infection, Dental itself; the rest are tagged with a narrower condition beneath it.

Get the Focal Infection, Dental report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Focal Infection, Dental trials start? (2)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2020 1
2013 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Focal Infection, Dental trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Phase 4 2

How many Focal Infection, Dental trials are recruiting? (2)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Completed 1
Withdrawn 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Focal Infection, Dental trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
GlaxoSmithKline 1

Which publications cover Focal Infection, Dental? (18)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Controversies in the Management of Oral and Maxillofacial Infections. Oral and maxillofacial surgery clinics of North America 2017 Yes
Microbiology and antibiotic sensitivity of head and neck space infections of odontogenic origin. Differences in inpatient and outpatient management. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 2017 Yes
Length of hospital stay and management of facial cellulitis of odontogenic origin in children. Pediatric dentistry 2014 Yes
The antimicrobial effectiveness of photodynamic therapy used as an addition to the conventional endodontic re-treatment: a clinical study. Photodiagnosis and photodynamic therapy 2014 Yes
Cervical necrotizing fasciitis with descending mediastinitis: literature review and case report. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2012 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages